Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse TACI/TNFRSF13B Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 4 publications
$200.50 - $561.50
Specifications
Antigen | TACI/TNFRSF13B/CVID |
---|---|
Concentration | LYOPH |
Dilution | Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Blockade of Receptor-ligand Interaction, CyTOF-ready |
Applications | Western Blot, Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF |
Classification | Polyclonal |
Description
TACI/TNFRSF13B/CVID Polyclonal specifically detects TACI/TNFRSF13B/CVID in Mouse samples. It is validated for Western Blot, Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF-ready.Specifications
TACI/TNFRSF13B/CVID | |
Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Blockade of Receptor-ligand Interaction, CyTOF-ready | |
Polyclonal | |
Goat | |
Mouse | |
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF13B, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B | |
TNFRSF13B | |
IgG | |
Affinity Purified | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
LYOPH | |
Western Blot, Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF | |
Unconjugated | |
RUO | |
Q9ET35 | |
23495 | |
Mouse myeloma cell line NS0-derived recombinant mouse TACI/TNFRSF13B Phe5-Thr129 Accession # Q9ET35 | |
Primary | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Detects mouse TACI/TNFRSF13B in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with recombinant human TACI is observed and less than 1% cross-reactivity with recombinant mouse BCMA/TNFRSF17 is observed. |
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title